Cullinan Therapeutics, Inc. ($CGEM)
Filing Information
| Accession Number | 0001193125-26-064256 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 23, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
27,742
Total Value
$199,766.04
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Feb 20, 2026 | Sale | 3,742 | $13.62 | $50,966.04 | 181,977 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Feb 20, 2026 | Exercise/Conversion | 8,000 | $4.30 | $34,400.00 | 189,977 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Feb 20, 2026 | Sale | 8,000 | $14.30 | $114,400.00 | 181,977 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Feb 20, 2026 | Exercise/Conversion | 8,000 | $0.00 | $0.00 | 124,987 | Direct | โ | View Details |